GSK3 and p53 - is there a link in Alzheimer's disease?
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent evidence suggests that glycogen synthase kinase-3beta (GSK3beta) is implicated in both sporadic and familial forms of Alzheimer's disease. The transcription factor, p53 also plays a role and has been linked to an increase in tau hyperphosphorylation although the effect is indirect. There is also evidence that GSK3beta and p53 interact and that the activity of both proteins is increased as a result of this interaction. Under normal cellular conditions, p53 is kept at low levels by Mdm2 but when cells are stressed, p53 is stabilised and may then interact with GSK3beta. We propose that this interaction has an important contribution to cellular outcomes and to test this hypothesis we developed a stochastic simulation model. RESULTS: The model predicts that high levels of DNA damage leads to increased activity of p53 and GSK3beta and low levels of aggregation but if DNA damage is repaired, the aggregates are eventually cleared. The model also shows that over long periods of time, aggregates may start to form due to stochastic events leading to increased levels of ROS and damaged DNA. This is followed by increased activity of p53 and GSK3beta and a vicious cycle ensues. CONCLUSIONS: Since p53 and GSK3beta are both involved in the apoptotic pathway, and GSK3beta overactivity leads to increased levels of plaques and tangles, our model might explain the link between protein aggregation and neuronal loss in neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a range of distinct aetologies, which manifest as a variety of different syndromes or diseases, converge at some point on an autocatalytic series of reactions, involving imperfectly liganded iron, in the production of the very damaging hydroxyl radical, that by causing the destruction of appropriate cellular structures and proteins liberates further ‘free’ iron and other reactive oxygen species,”
From Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples (2010) · cites this paper as Proctor and Gray 2010
Experimental — accuracy not yet measuredIn the citing paper
“GSK3β can also regulate p53 levels via MDM2 phosphorylation, which mediates p53 degradation.221”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [221]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Proceedings of the National Academy of Sciences
Richards, J. W. (1915) · Science · doi:10.1126/science.42.1074.161 · Cited by 13,983
Exact stochastic simulation of coupled chemical reactions
Gillespie, D. T. (1977) · The Journal of Physical Chemistry · doi:10.1021/j100540a008 · Cited by 10,136 · cited 1×
“Therefore, we use stochastic simulation based on the Gillespie algorithm [25].”
MethodInternational Journal of Molecular Sciences
(2024) · International Journal of Molecular Sciences · doi:10.3390/ijms · Cited by 10,111
Hucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano, H., Arkin, A. P., Bornstein, B. J., Bray, D., Cornish-Bowden, A., et al. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg015 · Cited by 3,060 · cited 1×
“Using the Systems Biology Markup Language (SBML) to build the model is ideal for this approach [18].”
MethodAmyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 1×
“Our results might seem contradictory to experimental data and the amyloid cascade hypothesis [34].”
ResultRequirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268 · cited 1×
“Since aggregates can only be detected when they are a certain size, this might explain why Ab plaques are often detected before tau tangles [33].”
BackgroundThe GSK3 hypothesis of Alzheimer’s disease
Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191 · cited 1×
“to put forward the ‘GSK3 hypothesis of AD’ [1].”
BackgroundRole of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway
Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,040 · cited 1×
“[2,3]).”
Dynamics of the p53-Mdm2 feedback loop in individual cells
Lahav, G., Rosenfeld, N., Sigal, A., Geva-Zatorsky, N., Levine, A. J., Elowitz, M. B., & Alon, U. (2004) · Nature Genetics · doi:10.1038/ng1293 · Cited by 1,013
Boutet, E., Lieberherr, D., Tognolli, M., Schneider, M., & Bairoch, A. (2007) · Plant Bioinformatics · doi:10.1007/978-1-59745-535-0_4 · Cited by 763
Le Novere, N. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj092 · Cited by 762 · cited 1×
“The model is publicly available on the BASIS website [22] and at the Biomodels database [23,24].”
MethodStochastic Modelling for Systems Biology
Wilkinson, D. J. (2006) · Chapman & Hall/CRC eBooks · doi:10.1201/9781420010664 · Cited by 736 · cited 1×
“We used SBML shorthand to code the model and then converted it to full SBML using a Python script [21].”
MethodCHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
Petrucelli, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh083 · Cited by 723 · cited 1×
“Although phosphorylated tau is resistant to degradation by proteases [36], it has been shown that phosphorylated tau is degraded by ubiquitin-dependent proteasome pathway and the heat shock proteins Hsp70, Hsp70, the ubiquitin ligase CHIP and the kinase Akt are all involved [37-39].”
BackgroundOscillations and variability in the p53 system
Geva‐Zatorsky, N., Rosenfeld, N., Itzkovitz, S., Milo, R., Sigal, A., Dekel, E., Yarnitzky, T., Liron, Y., Polak, P., Lahav, G., et al. (2006) · Molecular Systems Biology · doi:10.1038/msb4100068 · Cited by 653
Dickey, C. A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R. M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29715 · Cited by 642 · cited 1×
“Although phosphorylated tau is resistant to degradation by proteases [36], it has been shown that phosphorylated tau is degraded by ubiquitin-dependent proteasome pathway and the heat shock proteins Hsp70, Hsp70, the ubiquitin ligase CHIP and the kinase Akt are all involved [37-39].”
BackgroundSchneider, A., Biernat, J., von Bergen, M., Mandelkow, E., & Mandelkow, E.-M. (1999) · Biochemistry · doi:10.1021/bi981874p · Cited by 564 · cited 1×
“However, it has been shown that phosphorylation does not directly increase the propensity of tau to form aggregates [11,12] but rather that the effect is due to increased pools of unbound tau since phosphorylated tau is unable to bind to microtubules.”
BackgroundBeurel, E., & Jope, R. S. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.006 · Cited by 541 · cited 1×
“A solution to this paradox is that GSK3 has a pro-apoptotic effect on the intrinsic pathway but an anti-apoptotic effect on the extrinsic pathway [4].”
BackgroundProteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease
Keck, S., Nitsch, R., Grune, T., & Ullrich, O. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01642.x · Cited by 483 · cited 1×
“Similarly, it has been shown that paired helical filaments of tau inhibit the proteasome [10].”
BackgroundCellDesigner 3.5: A Versatile Modeling Tool for Biochemical Networks
Funahashi, A., Matsuoka, Y., Jouraku, A., Morohashi, M., Kikuchi, N., & Kitano, H. (2008) · Proceedings of the IEEE · doi:10.1109/jproc.2008.925458 · Cited by 464 · cited 2×
“Figure 3E shows the mean levels and standard deviations from 100 simulations and it can be seen that this is similar to the results of a deterministic simulation (see Figure 3F) using Cell Designer [32].”
ResultBILLINGSLEY, M. L., & KINCAID, R. L. (1997) · Biochemical Journal · doi:10.1042/bj3230577 · Cited by 453 · cited 1×
“Tau is phosphorylated by several different kinases but the Cdk5 and GSK3b kinases phosphorylate the sites which are implicated in AD [13].”
BackgroundAβ inhibits the proteasome and enhances amyloid and tau accumulation
Tseng, B. P., Green, K. N., Chan, J. L., Blurton-Jones, M., & LaFerla, F. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.014 · Cited by 384 · cited 1×
“For example, Tseng et al (2008) [9] show that small oligomers but not monomers of Ab inhibit proteasomes.”
BackgroundProteasomal degradation of tau protein
David, D. C., Layfield, R., Serpell, L., Narain, Y., Goedert, M., & Spillantini, M. G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01137.x · Cited by 327 · cited 1×
“Normal tau is also turned over by the 20S proteasome with a half-life of about 12-14 hours [14], whereas phosphorylated tau may be ubiquitinated and degraded by the 26S proteasome.”
BackgroundIntracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease
Ohyagi, Y., Asahara, H., Chui, D.-H., Tsuruta, Y., Sakae, N., Miyoshi, K., Yamada, T., Kikuchi, H., Taniwaki, T., Murai, H., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2637fje · Cited by 281
Glycogen Synthase Kinase-3β (GSK3β) Binds to and Promotes the Actions of p53
Watcharasit, P., Bijur, G. N., Song, L., Zhu, J., Chen, X., & Jope, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305870200 · Cited by 262 · cited 1×
“(2003) [31] whereby inhibition of GSK3b leads to 50% reduction in Mdm2 mRNA.”
BackgroundAkt and CHIP coregulate tau degradation through coordinated interactions
Dickey, C. A., Koren, J., Zhang, Y.-J., Xu, Y.-F., Jinwal, U. K., Birnbaum, M. J., Monks, B., Sun, M., Cheng, J. Q., Patterson, C., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709180105 · Cited by 226 · cited 1×
“Although phosphorylated tau is resistant to degradation by proteases [36], it has been shown that phosphorylated tau is degraded by ubiquitin-dependent proteasome pathway and the heat shock proteins Hsp70, Hsp70, the ubiquitin ligase CHIP and the kinase Akt are all involved [37-39].”
BackgroundRoe, C. M., Behrens, M. I., Xiong, C., Miller, J. P., & Morris, J. C. (2005) · Neurology · doi:10.1212/01.wnl.0000152889.94785.51 · Cited by 223 · cited 1×
“Interestingly studies have shown that AD patients have a lower incidence of several types of cancer [35].”
BackgroundProapoptotic Stimuli Induce Nuclear Accumulation of Glycogen Synthase Kinase-3β
Bijur, G. N., & Jope, R. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105725200 · Cited by 204
Presenilin-Dependent -Secretase-Mediated Control of p53-Associated Cell Death in Alzheimer's Disease
Alves da Costa, C., Sunyach, C., Pardossi-Piquard, R., Sevalle, J., Vincent, B., Boyer, N., Kawarai, T., Girardot, N., St. George-Hyslop, P., & Checler, F. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0651-06.2006 · Cited by 168
p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells
Hooper, C., Meimaridou, E., Tavassoli, M., Melino, G., Lovestone, S., & Killick, R. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.03.026 · Cited by 165 · cited 3×
“An interesting observation by Hooper et al (2007) is that p53 induces tau phosphorylation but that the effects are indirect since they observed p53 in the nucleus and tau in the cytoskeletal compartment [6].”
BackgroundInfluentialDoes p53 affect organismal aging?
Donehower, L. A. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10104 · Cited by 155 · cited 1×
“It is also plays an important role in ageing [5].”
BackgroundGlycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance
Kulikov, R., Boehme, K. A., & Blattner, C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7170-7180.2005 · Cited by 132 · cited 1×
“Another study showed that GSK3 can regulate p53 levels through the phosphorylation of Mdm2 [16].”
BackgroundExplaining oscillations and variability in the p53-Mdm2 system
Proctor, C. J., & Gray, D. A. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-75 · Cited by 132
Self-citationEidenmüller, J., Fath, T., Hellwig, A., Reed, J., Sontag, E., & Brandt, R. (2000) · Biochemistry · doi:10.1021/bi001290z · Cited by 117 · cited 1×
“However, it has been shown that phosphorylation does not directly increase the propensity of tau to form aggregates [11,12] but rather that the effect is due to increased pools of unbound tau since phosphorylated tau is unable to bind to microtubules.”
BackgroundTowards an e-biology of ageing: integrating theory and data
Kirkwood, T. B. L., Boys, R. J., Gillespie, C. S., Proctor, C. J., Shanley, D. P., & Wilkinson, D. J. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1051 · Cited by 111 · cited 1×
“We have developed our own system at Newcastle University, known as BASIS (Biology of Ageing e-Science Integration and Simulation system) [19,20].”
MethodSelf-citationProteolysis of Non-phosphorylated and Phosphorylated Tau by Thrombin
Arai, T., Guo, J.-P., & McGeer, P. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409234200 · Cited by 75 · cited 1×
“Although phosphorylated tau is resistant to degradation by proteases [36], it has been shown that phosphorylated tau is degraded by ubiquitin-dependent proteasome pathway and the heat shock proteins Hsp70, Hsp70, the ubiquitin ligase CHIP and the kinase Akt are all involved [37-39].”
BackgroundGillespie, C. S., Wilkinson, D. J., Proctor, C. J., Shanley, D. P., Boys, R. J., & Kirkwood, T. B. L. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btk042 · Cited by 44
Self-citationHongisto, V., Vainio, J. C., Thompson, R., Courtney, M. J., & Coffey, E. T. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02227-06 · Cited by 38
Proctor, C. J., Tsirigotis, M., & Gray, D. A. (2007) · BMC Systems Biology · doi:10.1186/1752-0509-1-17 · Cited by 34
Self-citationHsp90 Maintains the Stability and Function of the Tau Phosphorylating Kinase GSK3β
Dou, F., Chang, X., & Ma, D. (2007) · International Journal of Molecular Sciences · doi:10.3390/i8010060 · Cited by 33
Juty, N., & le Novère, N. (2013) · Encyclopedia of Systems Biology · doi:10.1007/978-1-4419-9863-7_1287 · Cited by 16
Akt and CHIP coregulate tau degradation through coordinated interactions
Cheng, J. Q., Jinwal, U. K., Dunmore, J., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/75j7-e290 · Cited by 7
Cited by
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…of appropriate cellular structures and proteins liberates further ‘free’ iron and other reactive oxygen species, thereby effecting positive feedback (also known as ‘vicious cycles’, Lin and Beal 2006; Proctor and Gray 2010; Proctor et al. 2007) that leads to the production of yet further damage.”
BackgroundInsulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer's disease
Akhtar, A., & Sah, S. P. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104707 · Cited by 279
Modelling the molecular mechanisms of aging
Mc Auley, M. T., Guimera, A. M., Hodgson, D., Mcdonald, N., Mooney, K. M., Morgan, A. E., & Proctor, C. J. (2017) · Bioscience Reports · doi:10.1042/bsr20160177 · Cited by 208
Self-citationGao, C., Hölscher, C., Liu, Y., & Li, L. (2012) · revneuro · doi:10.1515/rns.2011.061 · Cited by 164
“…that p53 and GSK3 β are both involved in the apoptotic pathway, and GSK3 β overactivity leads to increased levels of plaques and tangles, and the studies can also explain the link between protein aggregation and neuronal loss in neurodegeneration (Proctor and Gray , 2010 ; Meares et al. , 2011 ).”
BackgroundRole of p53 in Neurodegenerative Diseases
Chang, J. R., Ghafouri, M., Mukerjee, R., Bagashev, A., Chabrashvili, T., & Sawaya, B. E. (2012) · Neurodegenerative Diseases · doi:10.1159/000329999 · Cited by 134
Metadata
- Authors
- Proctor, C. J., & Gray, D. A.
- Affiliations
- Newcastle University (GB)
- University of Ottawa (CA)
- Corresponding author
- Proctor, Carole J
- Venue
- Molecular Neurodegeneration
- Published
- 2010
- Volume
- 5
- Issue
- 1
- Pages
- 7
- ISSN
- 1750-1326 (ISSN-L)
- PMC
- PMC2831894
- OpenAlex
- W2165280164
- Cited by
- 80
- References
- 42
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 6 · 2021: 7 · 2020: 9 · 2019: 2 · 2018: 7 · 2017: 8 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 4 · 2012: 3
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Molecular Neurodegeneration (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Alzheimer's Research Trust
- King's College London
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Alzheimer's disease, glycogen synthase kinase-3β, p53, protein aggregation, DNA damage, reactive oxygen species, MDM2, stochastic simulation model, neurodegeneration, tau hyperphosphorylation, apoptosis, amyloid plaques, neuronal loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.